Table 2.
Case | Age (years) | Sex | Tumor size (mm) | Classical/inverted | Follow-up after LECS (image) | Passage after LECS |
---|---|---|---|---|---|---|
1 | 91 | Male | 20 | Classical | Endoscopy; 3, 9, 20 months CT; 3 months |
No dissemination and recurrence, 42 months after LECS (alive) |
2 | 66 | Male | 10 | Classical | Endoscopy; 6, 18, 20 months CT; 16 months |
No dissemination and recurrence, 35 months after LECS (alive) |
3 | 75 | Male | 13 | Classical | Endoscopy; 3 months CT; 1, 21 months | No dissemination and recurrence, died of pneumonia 24 months after LECS |
4 | 83 | Male | 15 | Classical | Endoscopy; 15, 27 months CT; 11, 17, 23, 29 months |
No dissemination and recurrence, 33 months after LECS (alive) |
5 | 82 | Male | 20 | Inverted | Endoscopy; 3, 6, 11 months CT; 7, 12 months |
No dissemination and recurrence, 18 months after LECS (alive) |
6 | 74 | Male | 10 | Inverted | Endoscopy; 3 months CT; 2, 4, 7 months |
No dissemination and recurrence, 14 months after LECS (alive) |
7 | 81 | Male | 5 | Inverted | Endoscopy; 3 months | No dissemination and recurrence, 6 months after LECS (alive) |
LECS laparoscopic and endoscopic cooperative surgery, CT computed tomography